Ferro Uriguen, Alexander http://orcid.org/0000-0002-5484-9646
Laso Lucas, Esther
Sannino Menicucci, Cinzia
Iturrioz Arrechea, Izaskun
Alaba Trueba, Javier
EchevarrÃa Orella, Enrique
Gil Goikouria, Javier
Beobide Telleria, Idoia
Article History
Accepted: 5 May 2022
First Online: 21 June 2022
Declarations
:
: No sources of funding were received for the preparation of this article or the condut of this study.
: Alexander Ferro Uriguen, Esther Laso Lucas, Cinzia Sannino Menicucci, Izaskun Iturrioz Arrechea, Javier Alaba Trueba, Enrique EchevarrÃa Orella, Javier Gil Goikouria, and Idoia Beobide Telleria have no conflicts of interest that are directly relevant to the content of this study.
: The study was approved (approval number: EOM2021016) for execution by the Euskadi Drug Research Ethics Committee in Vitoria-Gasteiz (Basque Country, Spain).
: Given the characteristics of the study, the Euskadi Drug Research Ethics Committee exempted the need for informed consent. User identification data were anonymized in the database.
: Not applicable.
: Not applicable.
: Not applicable.
: AFU formulated the research question. AFU, ELL, CSM, IIA, and IBT contributed to the conception and design of the work. AFU, IBT, EEO, and JGG analyzed the data. The first draft of the manuscript was written by AFU. AFU, ELL, CSM, IIA, JAT, EEO, JGG, and IBT critically reviewed the manuscript. All authors approved the final version for publication.
Free to read: This content has been made available to all.